Blog

AppLovin (APP) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since

Remitly Global, Inc. (RELY) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might

SoundHound AI, Inc. SOUN posted standout second-quarter 2025 results, but one of the most telling metrics was its net revenue retention (NRR) — which surged from under 90% pre-acquisition to more

USA Compression Partners USAC reported a second-quarter adjusted net profit of 22 cents per common unit, which beat the Zacks Consensus Estimate of 21 cents. The metric improved from the year-ago

EverQuote, Inc. EVER has been trading above its 200-day simple moving average (SMA), signaling a short-term bullish trend. Its share price as of Monday was $23.55, down 21.6% from its 52-week high

Nova Ltd. NVMI shares have risen 3.7% since the company reported its second-quarter 2025 results on Aug. 7. The momentum can be attributed to better-than-expected results, as well as robust guidance

Victory Capital Holdings, Inc. VCTR reported assets under management (AUM) of $299.8 billion for July 2025. This reflected a marginal increase from June 30, 2025.

By asset class, VCTR’s U.S. mid-cap

Deere & Company DE is scheduled to report third-quarter fiscal 2025 results on Aug. 14, before the opening bell.The Zacks Consensus Estimate for Deere’s earnings has moved up 0.4% over the past 60

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates at the intersection of digital health and consumer wellness, leveraging a vertically integrated telehealth platform

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Smucker (SJM), which belongs to the Zacks Food

AllianceBernstein Holding L.P. AB has announced assets under management (AUM) for July 2025. The company’s preliminary month-end AUM remained unchanged at $829 billion compared with June 2025-end.

Rigetti Computing RGTI is taking an aggressive step to scale its quantum systems with a chiplet-based design — smaller, high-quality modules linked together to overcome the limits of single-chip

Cleanspark CLSK shares have lost 7.9% since the company reported its third-quarter fiscal 2025 results on Aug. 7. The decline can be primarily attributed to the challenging macroeconomic environment

The Estee Lauder Companies Inc. (EL) is likely to register declines in the top and bottom lines when it reports fourth-quarter fiscal 2025 earnings on Aug. 20. The Zacks Consensus Estimate for net

Xeris Biopharma (XERS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Grand Canyon Education (LOPE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Verona Pharma PLC American Depositary Share (VRNA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in

Relay Therapeutics, Inc. (RLAY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Adicet Bio, Inc. (ACET) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

BioLife Solutions, Inc. (BLFS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful